Home/Atmo Biosciences/Kate Hill

KH

Kate Hill

Chair of the Board

Atmo Biosciences

Therapeutic Areas

Gastroenterology Motility Disorders

Atmo Biosciences Pipeline

Drug	Indication	Phase
Atmo Gas Capsule System for GI Transit Times	Gastroparesis, Slow Transit Constipation, GI Motility Disorders	Approved

Leadership Team at Atmo Biosciences

Malcolm Hebblewhite

President & CEO, Co-Founder

Dr. Kyle Berean

Head of Clinical Affairs & Co-Founder

Head of R&D/Product Development & Co-Founder

Prof. Eamonn Quigley

Chair, Medical Advisory Board

View full Atmo Biosciences profile